NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

Not Yet RecruitingNA

Sponsor: University of Dayton

Conditions: Multiple Sclerosis (MS) Relapsing Remitting

Interventions: Powered Hip Flexion Orthosis (Hypershell X)

Countries: United States

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18-80
* Diagnosis of relapsing remitting, primary progressive or secondary progressive MS
* Unilateral or bilateral hip flexion weakness (Manual muscle testing score of 3 or less)
* Ability to walk at least 30 meters without requiring rest and without physical support or assistance from another person.
* Waist circumference 26-48", Height 5 '- 6'2", Weight 100-230lbs

Exclusion Criteria:

* Prior regular use of a hip flexion orthosis within the past 6 months.
* Cognitive or communication deficits that would limit ability to participate safely.
* Significant pain or deformity of the lower extremities that could impact walking ability.
* Severe spasticity (Modified Ashworth Score of 3 or 4) of the hips or lower extremities that could impact walking ability.
* Any other neurological conditions that may affect gait.

Locations (1)

Dayton, Ohio, United States